Undergraduate Medical Schools in Australia

Total intake not published on Adelaide University's current pages. Published sub-quotas only: "Adelaide University reserves approximately 41 places for students from a rural background"; "a number of places allocated specifically for Aboriginal and Torres Strait Islander applicants" (number not published); places offered as CSP in non-bonded (ABP171) and Bonded Medical Program (ABP271) streams, split not published. International: the degree page states "This degree is only available to Australian students" — no international intake published for this cycle.

Domestic only (Australian/NZ citizens, Australian permanent residents incl. permanent humanitarian visa holders). Selection rank/ATAR 90.00 confirmed, but the '(IB 33)' equivalent is unverified — do not publish as fact. The degree page makes no IB mention and the 2027 Health Study Guide lists 'IB score: NA' for this degree. — "Entry is highly competitive" and most successful applicants sit significantly higher. Prerequisite: any one of SACE Stage 2 Biology, Chemistry or Mathematical Methods (or equivalent). All applicants except Aboriginal and Torres Strait Islander pathway applicants must sit the UCAT ANZ in the year before entry (2027 entry: UCAT window 1 July – 5 August 2026). Interview shortlisting is by UCAT ANZ result; approximately 600 applicants are invited to interview, and "a minimum 50% of school leaver applicants invited for interviews will be from South Australia." Rural quota (~41 places): residence in MMM (2019) MM2–7 areas for at least 5 consecutive years or 10 years cumulatively. Non-school-leaver pathways: Higher Education (1–2 years of study at Adelaide University or antecedent institutions only, minimum GPA 5.0) and Work/Life Experience (competitive STAT, 18+ by 1 February) — all still require UCAT and interview. Strict quotas apply; late applications not considered. Progression to the MD requires completed BMSt from the university.

No subject adjustment factors: "The Adelaide University medical program does not consider subject adjustment factors, so the Universities Language, Literacy and Mathematics Scheme does not apply. Adjustment factors for the Bachelor of Medical Studies are only available under the Universities Equity Scheme" (size of equity adjustment not published on the degree page). Rural background: ~41 reserved places (quota, not a rank bonus). Aboriginal and Torres Strait Islander pathway: reserved places, UCAT ANZ waived, all eligible applicants invited to a dedicated ~20-minute interview conducted largely by Aboriginal and/or Torres Strait Islander panellists.

Multiple Mini Interview (MMI) — "a series of scenarios and questions, with a minimum of six stations lasting 10 minutes each." Aboriginal and Torres Strait Islander pathway applicants instead have an approximately 20-minute interview largely with Aboriginal and/or Torres Strait Islander panellists.

The University of Adelaide and the University of South Australia merged to form Adelaide University, which opened for its first intake in 2026 — the medical program is now offered under the new institution (SATAC codes ABP171/ABP271, Adelaide City campus) with the published 20/40/40 UCAT/interview/academic weighting. The current degree pages state the program "is only available to Australian students," whereas the antecedent University of Adelaide published international medicine admissions guides up to 2025 entry — no official announcement explaining the change was found. No changes to weighting, prerequisites or thresholds announced between 2026 and 2027 entry (the university's 2027 Health Study Guide repeats the same requirements and weighting).

Up to 40 domestic BHlthSc students receive conditional MChD offers each year, with approximately 30% of these places preferentially offered to rural-background students (current ANU page and GEMSAS 2027 note of ~40 reserved places; the January 2025 pathway guidelines PDF stated up to 30 domestic, 10 preferentially rural, plus up to 20 international pathway places — current international pathway numbers not published). Aboriginal and/or Torres Strait Islander students are considered in addition via the school's Indigenous Pathway. Bachelor of Health Science intake size itself: not published.

Entry to the Bachelor: minimum ATAR 90 (IB 35), no prerequisite subjects (chemistry recommended), compulsory supplementary form (2026 intake figures on ANU Programs & Courses). Pathway eligibility: minimum 72 units (12 courses) completed and on track for 96 units (16 courses) by 31 December of the application year, completed at ANU (max 1.0 FTE/48 units external credit); all compulsory 1000/2000-level courses plus the pre-medicine stream; minimum WAM 75% (best n-2 of n numerically graded courses) to be ranked for an offer; interview pass (minimum raw score 60%) required. No GAMSAT required. Final MChD offer conditional on completing the BHlthSc with minimum GPA 5.0 plus screening/vaccination requirements. Open to domestic and international students; no transfer into the BHlthSc permitted.

Approximately 30% of the pathway's domestic places preferentially offered to rural-background students; Aboriginal and/or Torres Strait Islander applicants considered in addition to the capped places via the Indigenous Pathway. No point/percentage bonuses published; standard ANU undergraduate adjustment factors apply to the initial BHlthSc admission (available from Selection Rank 70+).

Same online admissions interview as standard domestic MChD candidates, held in September: two parts with "a variety of direct and scenario-based questions"; pass mark 60% raw.

Domestic reserved places increased from up to 30 (January 2025 pathway guidelines) to up to 40 on current ANU and GEMSAS 2027-entry pages. Related feeder routes disestablished: the PhB (Bachelor of Philosophy Honours) pathway and the Tuckwell Scholarship pathway to the MChD apply only to students admitted in 2026 or earlier. No ANU-published notice that the Bachelor of Health Science pathway itself is closing was found on any primary source.

Bond entry-requirements page: "Each year, up to 180 domestic places can be offered into the Medical Program for May and September semester; 80% places for undergraduate applicants and 20% to graduate applicants" (i.e. ~144 undergraduate). NOTE: Bond's Medical Program FAQ page states "up to 200 domestic places" with the same 80/20 split — the two Bond pages conflict; re-verify before publishing. All places are full-fee (private provider): 0 CSP; Bond explicitly does not participate in the Bonded Medical Places (BMP) Scheme; 0 international places in this stream ("not available to international students who intend to apply for a student visa").

Domestic only: Australian citizens, permanent residents, Australian humanitarian visa holders, and New Zealand citizens (NZ permanent residents excluded). Year 12 completers with no COMPLETED tertiary study — Bond's FAQ defines an undergraduate applicant as someone who has completed a High School Senior Certificate 'with, or without, incomplete tertiary studies'; only completed tertiary qualifications push an applicant into the graduate stream. (QTAC's prerequisite line reads 'No prior tertiary study', which conflicts with Bond's own more precise definition.). Minimum competitive academic result: ATAR 96+ (or OP 1-3) or IB Diploma 38+. Prerequisite: QCAA English / EAL / Literature / English & Literature Extension Units 3&4 grade C or better (interstate/IB equivalents accepted). No UCAT and no GAMSAT — Bond uses its own proctored online psychometric testing (emotional-intelligence + personality tests, ~90 min, ~$346.50 GST-incl in 2025) plus an interview.

Bond FAQ: "Adjustment factors cannot be used for the Bond Medical Program" — no ATAR bonus schemes. Geographic interview quota: "From 2025, the Medical Program aims to ensure that 40% of interview invitations are extended to candidates from Queensland and the Tweed community." First Nations: dedicated First Nations pathway into the Medical Program plus the Bond University First Nations Medical Partial Scholarship.

Individual online interview, approximately 90 minutes including registration and debriefing (Bond does not describe it as an MMI), assessing "general suitability to medicine and preparedness to undertake a highly demanding course". 2027-cycle interviews: 9-12 March 2027, online.

From the 2025 cycle Bond introduced the 40% Queensland/Tweed-community interview-invitation target (published on its entry-requirements page). Applications are now lodged via QTAC (codes 020712/020741) rather than direct to Bond. Psychometric results validity rule: results from test versions taken before October 2025 are no longer valid (24-month validity). No announced changes to weightings, seats or campuses beyond these.

Pathway capacity published as 'up to 60 students per year' across Rockhampton + Bundaberg (CQU/UQ partnership announcement). Rockhampton-vs-Bundaberg split: not published. CSP-vs-BMP numeric split: not published — CQU states '28.5% of the Medical Pathways cohorts are required to be on the Bonded Medical Program' (the federal BMP quota rate); the balance are Commonwealth supported. International: not available (domestic pathway only).

Hard gates per CQU's CM17 Entry & Admission document (July 2026): (a) Australian or NZ citizen, Australian permanent resident, or permanent humanitarian visa holder; (b) completed Grade 12 at first attempt in the year of application (school leavers only; deferment of commencement not permitted); (c) prerequisites: English (Units 3&4, C), Mathematical Methods (Units 3&4, C), and one of Biology/Chemistry/Physics (Units 3&4, C); (d) adjusted ATAR 95.00 or higher (or equivalent selection rank); (e) UCAT ANZ sat in the year of application; (f) attend MMI if selected. A tiered rurality system governs both interview invitation and offers: Tier 1 = candidates from the Medical Pathways footprints (MM2-7 in CQ/Wide Bay), Tier 2 = other regional/rural (MM2-7) Queensland, Tier 3 = other regional/rural (MM2-7) rest of Australia, Tier 4 = all other candidates — the Entry & Admission PDF defines it slightly differently at each stage: for INTERVIEW invitation 'All other candidates, with 50% from Queensland', and for OFFERS 'All other candidates, including MM1'. Progression to the UQ MD requires gaining admission in the year of the provisional offer, completing the CQU degree in minimum time and passing all units; The exact quote 'within three years and with a Grade Point Average of 5.0 or more' appears on the QTAC course listings (all six codes), not the CQU course page (which currently has no GPA statement). The CQU Handbook (CM17) states the GPA part only: 'Upon successful completion of the course with a Grade Point Average of 5.0 or more, you will gain direct entry...'. Substance is verified; the attribution should cite QTAC listings and the CQU Handbook. Note the July 2026 Entry & Admission PDF itself specifies only minimum-time completion + pass all units, with no GPA.. Alternative Aboriginal and/or Torres Strait Islander Admission Pathway is open to school leavers AND mature-age applicants (semi-structured interview panel; prerequisite subjects at panel discretion for mature-age).

QTAC-administered adjustments, maximum 5 across all schemes (per the Entry & Admission document). As published on CQU's 'Regional Medical Pathway in Detail' page: Rural Access Scheme — 2 points for rural background (Modified Monash Model) or 3 points for rural background within Central Queensland/Wide Bay (residence 10 years cumulative or 5 consecutive); CQ/Wide Bay Schooling Adjustment — 3 points for permanent residence plus Years 11–12 completed in CQ/Wide Bay; Subject Incentive Scheme — 2 points for a Language other than English (Units 3&4, C+), 2 points for Specialist Mathematics (Units 3&4, C+); Start Uni Now (SUN) units — max 1 point. Aboriginal and Torres Strait Islander Admission Pathway runs as a separate scheme (semi-structured interview based, selection on recommendation of CQU's Indigenous Engagement Division).

Multiple Mini Interview (MMI), minimum score usually 40/80, worth 50% of the final offer score. The Aboriginal and/or Torres Strait Islander pathway uses a semi-structured interview panel plus MMI. Most recent published MMI dates were 25–27 November (held in the application year).

Partnership renewed for another five years (announced June 2024 by CQU/UQ). UQ announced (March 2025) a target to increase First Nations doctors in Central Queensland. The RMP model is also being replicated as the separate Darling Downs–South West Medical Pathway (UQ/UniSQ) — a distinct program, not a change to this one. Weighting/quota/campuses are indeed unchanged, but the statement misses the material structural change reflected in the 2027-entry course documents: the pathway is now presented as SIX years total, with CM17's third year embedding UQ MD year 1 (CQU course page for Term 1 2027 and CQU Handbook), replacing the original 3+4 = 7-year description that still appears on older CQU/QTAC pages. This parallels UQ's new 6-year BMedSc/MD vertical dual program announced for 2027 entry (a separate metro program, but the same shortened structure).

Domestic: "In 2027 approximately 110 places will be available" (2027 Domestic Admissions Guide). CSP/BMP split not published by Curtin — the guide cites only the national policy figure that "approximately 28% of Commonwealth Supported Places in university medical programs across Australia are set aside for the Federal Government's Bonded Medical Program". Up to 25% of places allocated to the Rural entry pathway. Domestic full-fee: not offered/not published. International: "10 to 15 International full-fee paying places available for the 2027 intake" (2027 International Admissions Guide); indicative Year 1 international fee AUD $100,782.

School leavers (primary target): minimum ATAR 95 (or equivalent Year 12), no prior post-secondary/higher-degree record. Non-school leavers (graduates): completed degree with minimum notional ATAR 92 (guide: Bachelor at Distinction average; Grad Dip/PG Dip Credit average; Master's/Doctorate awarded) — enters the same 5-year MBBS, no graduate-entry MD exists. Curtin course switchers: minimum CWA 80, ≥200 credits completed and ≥200 remaining. Prerequisite: Chemistry ATAR final scaled score ≥50 (or IB Chemistry HL/SL grade 4+, NCEA L3 Chemistry 24 credits, or two first-year university chemistry units at 60+; bridging units not accepted). UCAT ANZ required + Casper test required (domestic) — both exempt for Aboriginal and Torres Strait Islander pathway applicants and both NOT required for international applicants. STAT not accepted (English competency only). Domestic = Australian citizens, PRs, NZ citizens; BMP restricted to Australian citizens/PRs (NZ citizens ineligible). Degree is "primarily for Western Australian school leavers"; interstate applicants eligible but WA rural/Indigenous/equity candidates prioritised. Rural pathway: WA/NT/SA applicants with MM2-7 background (10 years cumulative or any 5 consecutive since Year 1). Applicants excluded from another medical school are ineligible; incomplete degrees from other institutions ineligible. International academic minima include ATAR 95 / IB 39 / GCE A-levels 14; IELTS 7.0 in all bands.

Rural entry pathway (WA/NT/SA rural background, MM2-7): up to 25% of places quarantined, plus "up to a maximum of five additional adjustment points to their ATAR, or Notional ATAR" via the CMS Rural adjustment scheme OR Curtin StepUp (one scheme only, max adjusted ATAR 99.95). Equity entry pathway (WA school leavers eligible for Curtin StepUp — qualifying schools list or financial hardship): StepUp Bonus "adjusts eligible applicant's ATAR by five points, up to a maximum of 99.95"; equity applicants compete only against other equity applicants. Aboriginal and Torres Strait Islander entry pathway: direct application to CMS, no TISC, UCAT and Casper both waived; selection via Formal Yarning Session with the Aboriginal Health Team then MMI. Special consideration only via TISC's Educational Access Scheme (EAS). No elite-athlete, research-degree or health-employment bonuses published.

Multiple Mini Interview (MMI); primarily face-to-face in Perth with limited online interviews (e.g. interstate/overseas). Rounds: December round covers 'Competitive and eligible Western Australian school leavers, Curtin course switchers and Western Australian non-school leavers' (Predicted ATAR used for the WA school leavers only), MMIs 3 and 7 December 2026 (subject to change)., mid-January (actual-ATAR competitive WA applicants holding Curtin first preference at 28 Dec, MMI 7 Jan 2027), late January (non-WA applicants, online, 22 Jan 2027). Attendance mandatory. International applicants: interview (may be conducted online via Microsoft Teams, up to an hour); The 2027 International Admissions Guide's Key dates section explicitly says 'Invitations for Multiple Mini interviews — July for July/August interviews (subject to change)', so Curtin does label the international interview an MMI (the body text just calls it 'the interview', conducted online via Microsoft Teams up to an hour)..

Total intake not published. Published sub-quotas: Indigenous sub-quota "up to five places" annually; rural and remote sub-quota exists but its size is not published. Places are Commonwealth Supported (CSP); international places also offered via a separate international route.

School leavers only — applicants "must not have a record of study at higher education level". Minimum Year 12 ATAR of 95.00 or above (or equivalent) to be considered; Indigenous sub-quota minimum ATAR 90 or above (after eligible adjustments) plus a competitive UCAT rank. Must sit UCAT ANZ. No Year 12 prerequisite subjects. Domestic citizenship (Australian citizen/PR); apply via SATAC. Rural and remote sub-quota: residency of 5 consecutive years or 10 cumulative years in ASGS RA2–RA5, evidenced by Statutory Declaration submitted to SATAC within 10 working days of application. Progression into the MD requires a minimum GPA of 5.0 in the Bachelor of Clinical Sciences.

SATAC Universities Equity Scheme adjustment factors apply (sizes not published on the course page); the minimum competitive ATAR of 95 is stated as "after the addition of any relevant adjustment factors". Indigenous sub-quota lowers the ATAR floor to 90. No other bonus schemes published.

None — "An interview is not required."

For 2027 entry, rural/remote sub-quota eligibility "will only be assessed using the 'ASGS Remoteness Area' '2021' layer". No other announced changes found.

12 places annually per CDU's published quota: 5 NT resident, 5 NT First Nations, 2 national First Nations

Australian citizens and permanent residents only. School leavers with Year 12 (or higher-education students with no more than one year of study). Competitive ATAR stated as 90 or above (85 or above for First Nations applicants), after applicable adjustment factors. UCAT ANZ required. Progression: "required to pass all units and gain a minimum Grade Point Average (GPA) of 5.00 (Credit Average)" in the first two years, within the specified time frame, which "guarantees entry into the NTMP".

First Nations applicants: lower competitive ATAR threshold (85 vs 90) and dedicated quota places (5 NT + 2 national First Nations of the 12). ATAR adjustment factors apply via SATAC; sizes not published.

None published for entry to the Bachelor of Clinical Sciences (selection is ATAR + UCAT ranking).

30 places at Gold Coast + 30 places at Brisbane South (Nathan) (published on Griffith's Pathways to Medicine page). These feed the 80 BMedSci-pathway places reserved within the MD's CSP/BMP totals (28.5% BMP per GEMSAS). CSP/BMP split of the BMedSci intake itself: not published.

Currently in Year 12 or completed Year 12 within the past year, with NO prior tertiary study at diploma level or higher; English language proficiency; assumed knowledge (not assessable per Griffith): General English, Mathematical Methods, and one of Biology/Chemistry/Physics (QTAC listings show these at Units 3 & 4, C). UCAT ANZ optional but strongly recommended. Progression to MD requires completing the BMedSci with GPA ≥5.5 — then guaranteed MD admission with NO GAMSAT and NO GUMSAA interview.

ATAR adjustments of up to 0.25 total based on location, rurality, Educational Access Scheme (EAS), and/or the Elite Athlete Support Policy. Rural applicants (MM2–MM7, assessed rural by QTAC) receive a published 0.05 ATAR/Rank adjustment. First Peoples Health Pathway available for Year 12 students (culturally appropriate process; details via GUMURRII).

None — no interview for BMedSci entry, and the guaranteed transition to the MD also waives GUMSAA.

Capped at 20 annually per the QTAC listing (CSP; program is domestic-only). These places sit within the 80 BMedSci-pathway places reserved in the Griffith MD intake (28.5% BMP per GEMSAS).

Current or recent Year 12 (within one year) with no prior tertiary study; domestic students only; General English recommended. UCAT ANZ optional (used for ranking). Progression to the Griffith MD requires a minimum GPA of 5.50 in the BMedSci — eligible graduates get direct admission without GAMSAT or GUMSAA.

No ATAR adjustment factors apply (explicitly published by UniSC; Access UniSC and QTAC EAS do not apply). Instead, limited sub-quota places at a lower published threshold (99.30 in 2026) via the Rural Access Scheme, the Regional Health Workforce Scheme (local-area residents), and an Indigenous medical access pathway.

None — no interview for entry, and the transition to the Griffith MD waives GUMSAA.

Domestic: 'In 2027, JCU has approximately 170 places across both Townsville and Cairns for the Bachelor of Medicine, Bachelor of Surgery course for domestic applicants' (2026 comparison: approximately 180). CSP vs Bonded Medical Program (BMP) split: not published — JCU confirms BMP places exist ('applicants cannot request the type of place they may be offered') but publishes no numbers. Per-campus split: not published. Full-fee domestic: not offered/not published. International places: not published. Rural Access Scheme reserved places: number not published.

NO UCAT and NO GAMSAT — JCU's published wording: 'JCU does not use the University Clinical Aptitude Test (UCAT) or Graduate Medical School Admissions Test (GAMSAT) as part of the selection process. Applicants who sit these tests receive no advantage or improved consideration.' Prerequisite subjects (must be completed BEFORE an offer; no conditional offers): English (Units 3/4, C), Mathematical Methods (Units 3/4, C), Chemistry (Units 3/4, C); Specialist Maths satisfies Maths Methods; any QLD Year 12 English satisfies English; JCU Prep bridging can meet prerequisites for those who have finished Year 12. No set ATAR threshold for domestic school leavers ('JCU does not have set ATAR thresholds for entry to Medicine'). Non-school leavers (finished school >2 years ago and/or ≥1 FTE tertiary study) MUST have ≥1 FTE of bachelor-level-or-higher tertiary study within the last 10 years; minimum unweighted GPA 5.75/7 'to be considered competitive' (not a guarantee); most recent GPA weighted highest but entire academic profile considered; 'consideration is given for studies in health'. International applicants: published 2027 minimum competitive scores include ATAR 94, IB 38, GCE A-Levels 15, tertiary GPA 5.75/7, SAT 1360/ACT 31; English proficiency Band 3b of the JCU Admissions Policy. Domestic = Australian/NZ citizens, permanent residents, permanent humanitarian visa or Pacific Engagement Visa holders. Year 12 domestic applicants must have a school official submit a Prediction of Academic Achievement (PAA) form (used only to schedule first-round interviews; offers based on actual results only). Inherent requirements apply; Blue Card and vaccinations required post-offer.

No score adjustments: 'ATAR or selection rank adjustment programs including the Regional Preference Scheme, Educational Access Scheme and Subject Adjustment Scheme are not available for Medicine, Dentistry or Veterinary Science applicants.' Instead, two published entry schemes: (1) QTAC Rural Access Scheme — reserved places (number not published) for applicants who lived in a designated rural/remote area of anywhere in Australia for at least 5 consecutive years (60 months) or 10 years cumulatively (120 months); all JCU medicine applicants are automatically invited to apply (QTAC cover sheet + documentary evidence; closes 29 September 2026). (2) Indigenous Selection Pathway — designated recruitment and selection pathway for Aboriginal and/or Torres Strait Islander applicants; requires QTAC + JCU applications plus an endorsed Confirmation of Indigenous status letter (issued, signed and sealed by an incorporated Indigenous community organisation) emailed to indigenoushealthpathway@jcu.edu.au. Rurality is also a stated element of the main selection process (no size published).

Online live panel interview via the Kira Talent platform. Domestic: 'Panels typically include a health practitioner, an academic staff member and a member of the community.' International: live with two panel members. Not an MMI. Two domestic rounds, both before any offers: Round 1 invites 6 November 2026, interviews 24 November – 1 December 2026; Round 2 invites 21 December 2026, interviews 6–7 January 2027 (second round covers applicants whose PAA was inaccurate or missing). Interviewees pay Kira Talent a platform fee (approx. USD $20 plus tax, current as at February 2026). Interview assesses 'attributes suited to a career in medicine'; JCU publishes no question guidance.

No announced changes to selection criteria or weighting for the 2027 cycle. Context officially published by JCU: the full 6-year MBBS in Cairns is now established (inaugural Cairns first-year cohort commenced 2023, backed by a Federal Government commitment of $13.2m for 20 Commonwealth Supported Places for the Cairns program, announced March 2022); the Yeinie Building clinical training facility adjacent to Cairns Hospital opened in early 2026. Published domestic places moved from approximately 180 (2026 intake) to approximately 170 (2027 intake) — both figures are JCU's own 'approximately' wording, not an announced cut. Note for graduate applicants: JCU offers NO graduate-entry MD and no provisional/assured school-leaver pathway — graduates apply to the same MBBS as non-school leavers (limited study credit may be available after an offer).

Not published for the Bachelor of Clinical Science. (The downstream MD has 60 full-fee domestic places per GEMSAS 2027.)

Selection rank 90 (2026 course page) via UAC; Commonwealth Supported Place for the bachelor (estimated AUD $11,100/year, 2026). IMPORTANT: this is explicitly described by Macquarie as an 'indirect' pathway — 'Separate admission requirements apply for each course', and graduates must still meet all MD minimums (weighted GPA 5.0/7.0, GAMSAT 50 overall and 50 per section) and apply through GEMSAS. There is no guaranteed or provisional MD place for domestic students.

Published advantages for BClinSci graduates applying to the Macquarie MD: automatic 3 per cent bonus to weighted GPA; up to 30 MMI (interview) places reserved for BClinSci graduates who would not otherwise have received an interview — the course page states top-30 GEMSAS-admissions-ranked BClinSci students who meet minimum MD entry requirements are 'guaranteed an interview for the MD'; up to 5 graduate scholarships.

None for bachelor entry (UAC rank only). MD stage uses the standard Macquarie MMI.

Not published — Macquarie states only that 'Entry is competitive and this program package has a set quota for places.' (The MD itself has 20 international places per GEMSAS 2027.)

International high-school graduates only (no domestic equivalent). Selection requirements published by Macquarie: competitive secondary school results (a minimum final examination mark equivalence applies — exact threshold in the International Admissions Guide); satisfactory performance in an online Multiple Mini Interview; IELTS 7.0 overall with minimum 7.0 in each band (or equivalent); assumed knowledge of mathematics and chemistry (bridging available if not completed). Conditional automatic progression into the MD — without GAMSAT/MCAT or further selection — requires: holding an unconditional place in the combined package, completion of the Bachelor of Clinical Science with a minimum WAM of 70, and a minimum WAM of 70 in the professional practice units.

None published for package entry. (BClinSci graduates who instead apply to the MD in open competition receive the 3 per cent weighted-GPA adjustment, which Macquarie states applies to domestic and international BClinSci graduates.)

Online Multiple Mini Interview comprising four short interview stations of a maximum of eight minutes each.

Not published as a separate quota. GEMSAS notes the 179 CSPs 'are also available to eligible Chancellor's Scholars applicants' and the up-to-105 full-fee places 'are also available to eligible Guaranteed Entry Full-Fee applicants'.

Chancellor's Scholars (CSP for domestic / international fee place for internationals): current or recent University of Melbourne student (studies completed within 18 months before 1 Jan of MD commencement) who entered the University with an ATAR of 99.90+ from an Australian Year 12 or IB in Australia, immediately following Year 12 (or with approved deferral). Guaranteed Full-Fee (domestic full-fee or international fee place): same conditions with ATAR 99.00+, and a final course Weighted Average Mark of 75 or above required to confirm the offer. No GAMSAT required for either cohort. WAM (not GPA) is the entry score; honours results are excluded from the guaranteed-pathway WAM.

None published (this pathway is itself the adjustment: guaranteed place, no GAMSAT). GAM can be completed as part of the direct application.

Multi-Mini Interview (satisfactory standard required, tests communication skills); Guaranteed Entry MMIs held mid-September 2026.

GEMSAS 2027 guide states: for applicants who commence undergraduate study after January 2027, 'the details of the Guaranteed Full Fee Entry pathway... will be confirmed later in 2026' — i.e. the ATAR-99.00 full-fee guarantee as currently described applies only to students who commenced undergraduate study before January 2027; replacement terms not yet published.

17 bonded CSPs in the 2027 MD intake reserved for graduates of La Trobe's Bachelor of Biomedical Science (Medical) (within the 32 MD Rural Pathway places).

Be currently enrolled in / a graduate of the Bachelor of Biomedical Science (Medical) (AQF7) at La Trobe University (a rural-background-restricted degree). Handbook: meeting rural-pathway requirements 'does not guarantee selection (except for completion of the Bachelor of Biomedical Science (Medical) at La Trobe with the required WAM)'. GAMSAT not required. Domestic applicants only; places are bonded CSPs. Entry criteria into the La Trobe degree itself (ATAR, rurality screening, interview) are set and published by La Trobe/VTAC — verify on La Trobe's course page.

None published beyond the guarantee itself (reserved bonded CSPs, no GAMSAT, rurality evidenced by the degree).

Rural-specific MMI applies to the MD Rural Pathway; the guarantee for La Trobe graduates is conditioned on WAM 70% (Handbook wording quoted above). MMI selection into the La Trobe undergraduate degree is administered by La Trobe.

20 May 2026: 2 additional Commonwealth-funded CSPs to the Shepparton Rural Medical School from 2027, described as growing the existing La Trobe partnership pathway.

Approximately 234 domestic students accepted each year at Clayton, all admitted on Commonwealth Supported Places (CSP); 30 of these places held for the Extended Rural Cohort (ERC, all CSP); 'approximately 28.5% of all domestic places must be set aside as Bonded Medical Places (BMP)' per Federal Government advice. Minimum 27% of all domestic places reserved for Dean's Rural List applicants. Approximately 90 international students are accepted into the direct entry medicine program at Clayton campus each year (published on Monash's international direct-entry page, last updated 29 April 2026).

Only open to applicants who completed Year 12 (or equivalent) no more than two years prior to commencement and have NOT commenced any tertiary study (Certificate IV and above makes you ineligible — such applicants must use graduate entry). Minimum ATAR 90 (final cut-offs significantly higher). Prerequisites: VCE Units 3&4 English (study score 35 EAL / 30 English other than EAL) and Chemistry (study score 30); IB minimum 39 overall with English (5 SL/4 HL or English B 6 SL/5 HL) and Chemistry (5 SL/4 HL). Biology not required. UCAT ANZ compulsory for all domestic applicants (sit in 2026 for 2027 entry); situational judgement subtest used only as a tie-break between equal total scores. International applicants sit ISAT instead: minimum overall 170 with at least 165 in both Critical Reasoning and Quantitative Reasoning (2027-intake interview cut-off was overall 178). Domestic = Australian/NZ citizen, permanent resident, or permanent humanitarian visa holder. Applicants may attend the MMI only once, ever.

Dean's Rural List (DRL): minimum 27% of domestic places reserved for applicants with Australian rural background (principal home address in MM2-MM7 for 5 consecutive or 10 cumulative years); DRL applicants had a much lower December-interview UCAT cut-off (2026 intake: 2050/66th percentile vs 2380/94th percentile non-DRL Victorian). Equity schemes (SEAS): ATAR-related adjustments up to 20 aggregate points (up to 10 ATAR points) at Monash, feeding directly into the ATAR-aggregate selection component; categories include Indigenous Australian, low-SES/regional location, non-English speaking background, first in family, difficult life circumstances, financial hardship, disability. Indigenous Entry Scheme: Indigenous Australian applicants are exempt from competitive ranking — an all-Indigenous panel interview replaces both the UCAT ANZ and the MMI. Extended Rural Cohort: 30 CSP places under a separate VTAC code, open to rural or urban background, no return-of-service obligation.

Multiple Mini Interview (MMI), conducted online via Zoom: six sequential 10-minute stations (2 min reading + 8 min interview) assessing advocacy, collaboration, critical thinking, empathy, ethical reasoning, motivation and resilience; circuit 70-80 minutes — this six-station format applies to DOMESTIC applicants; international applicants sit a four-station MMI (same seven attributes, held on Zoom; main round 21–22 July 2026, VTAC-route 19 November 2026). Interview rounds: December (DRL 1-2 Dec 2026; Victorian non-DRL 8-9 Dec 2026), January second round (4-5 Jan 2027), January third round for interstate/overseas Year 12 (18-19 Jan 2027). Applicants may sit the MMI once only. Indigenous Entry Scheme applicants do a panel interview instead.

170 places per year across both universities combined (published; "more than 3,000 people apply"). Published sub-quotas: rural target 30% of students via Rural and Remote Admissions Scheme (18 at UNE and 33 at UON); up to 17 places for Aboriginal and Torres Strait Islander applicants (Miroma Bunbilla Program); up to 6 places Excellence through Equity Pathway (UON Open Foundation students); up to 10 places Regional Health Professional Pathway. Places are CSP (UNE lists the course as Commonwealth Supported; est. first-year student contribution $13,536). Bonded Medical Program (BMP) quota exists (policy names a "Bonded Medical Places" quota) but the BMP number is not published. International quota: not published (2026 indicative international fee $92,695/yr, CRICOS 082394J).

Domestic school-leaver route: minimum ATAR 94.30 (HSC or equivalent); minimum ATAR 85 for applicants who completed Year 12 at a school in a designated rural/remote location (Rural Bonus Scheme, school address MM2-7 under the Modified Monash Model). Tertiary route: at least 1 year full-time (1 EFTSL, excluding credit) in a single program — policy requires a UAC (ATAR-based) rank of 88.40 or better; the JMP website publishes an equivalent table (e.g. completed bachelor "better than pass average", incomplete bachelor "close to credit average", GradDip credit average, research masters/PhD awarded). UON Bachelor of Biomedical Science graduates (completed 2025 or 2026): GPA 4.3+ with the lower (rural) UCAT cut-off. UCAT ANZ compulsory for all standard applicants (domestic and international); JMP uses an aggregate of Verbal Reasoning + Decision Making + Quantitative Reasoning only — Situational Judgement is not used for 2027 admission; UCAT cut-off for interview invitation set after applications close, lower cut-off for rural (RRAS), Communities Entry List and BiomedSci-pathway applicants. UCAT waived for: Regional Excellence Pathway (current school-leavers with ATAR 99.00+ from a school in the Hunter New England/Central Coast LHDs), Regional Health Professional Pathway (AHPRA-registered nurses/physios/paramedics/pharmacists with 2+ years living and working in MM3-7 areas of the HNELHD), and Miroma Bunbilla (Aboriginal and Torres Strait Islander) applicants. RRAS and Communities Entry List require Australian citizenship/PR (NZ citizens ineligible); 5 years consecutive or 10 years cumulative residence. No subject prerequisites; no age limit. International: onshore/offshore school-leavers and tertiary applicants accepted (IELTS 7.0 overall/7.0 each section; Genuine Student requirement).

Educational Access Scheme (UAC EAS): up to 4 additional adjustment points toward academic eligibility (JMP participates). Rural Bonus Scheme: minimum ATAR drops from 94.30 to 85 for applicants whose school was in an MM2-7 location. Rural and Remote Admissions Scheme (RRAS) and JMP Communities Entry List (Hunter New England / Central Coast / Mid-North Coast LHD residents): lower UCAT ANZ cut-off for interview invitation. Biomedical Science Pathway (UON graduates, GPA 4.3+): rural-level (lower) UCAT cut-off, uncapped progression to interview. Regional Excellence Pathway: interview offered without UCAT for ATAR 99.00+ footprint school-leavers. Regional Health Professional Pathway: UCAT waived, up to 10 places. Miroma Bunbilla Program (Aboriginal and Torres Strait Islander): separate admission process, no UCAT and no direct JMP application required; up to 17 places. No generic elite-athlete or research-degree bonus published.

"Multiple Skills Assessment" (MSA): several eight-minute rotating stations discussing scenarios and undertaking activities with an assessor (MMI-style), held at Newcastle (Callaghan) or Armidale late November–early December 2026, plus the Personal Qualities Assessment (PQA), an online psychometric test completed the same day (PQA used only when the MSA is face-to-face). Assessed domains published: capacity to thrive in the JMP learning environment; everyday/important decision-making under uncertainty; interpersonal and communication skills; desire/drive to be a doctor. International applicants: MSA conducted via Zoom. Situational Judgement (UCAT subtest) explicitly not used for 2027.

Published for the 2027 cycle: the UCAT ANZ Situational Judgement subtest "will not form part of the JMP selection process for admission 2027" (aggregate = Verbal Reasoning + Decision Making + Quantitative Reasoning only). The university also states it "has introduced the UCAT ANZ for international applicants as part of the selection process", and the Regional Health Professional Pathway (up to 10 places, UCAT waived) and Regional Excellence Pathway (ATAR 99.00+ footprint school-leavers, UCAT waived) are current published pathway additions. No announced changes to total intake or weightings found.

Not published. Notre Dame states: "Each year, a defined number of places in Medicine are reserved for eligible Notre Dame Biomedical Science graduates" and GEMSAS states "Places will be distributed across each campus and fee type in a similar pattern to general place offers" — no numeric quota is published.

Reserved-entry (NOT guaranteed) pathway: candidates "compete within your cohort rather than against the broader national applicant pool". Must have been initially admitted to the UNDA Bachelor of Biomedical Science (incl. Biomed/Laws or Biomed/Commerce double degrees) with a valid ATAR selection rank, from 2024 onwards. Must apply in the year of degree completion or the year after (once only); not eligible if further study at another tertiary institution was undertaken after completion; max 1.0 FTE credit from another degree (excluding transfer between UNDA Biomed degrees). Must meet all standard GEMSAS entry requirements PLUS: GEMSAS-calculated GPA ≥6.0, unweighted GAMSAT ≥55, and a Casper score no lower than 1 SD below the mean. Must preference Notre Dame Fremantle & KCRMT Broome or Notre Dame Sydney first in GEMSAS.

None specific to the pathway published; standard MD bonus points (rurality MM2-7, WA residency 10+ years, HDR completion) apply within the GEMSAS application.

Standard MD interview — online recorded (asynchronous) Multiple Mini Interview (MMI).

This pathway is NEW: "the first Priority Entry commencing in the 2026–2027 intake", for students first admitted to the Bachelor of Biomedical Science from 2024 onwards. It supersedes the former domestic UCAT-based Bachelor of Biomedical Science (Assured Pathway) — the domestic Pathways to Medicine page now lists only the Priority Entry Pathway as the undergraduate route, and the former assured-pathway program URL now resolves to the plain Bachelor of Biomedical Science page (the Assured Pathway remains advertised for international students only).

Not published (international full-fee only; note the graduate MD international estimate is "Up to 15" at Fremantle for 2027, but no assured-pathway quota is published).

International school leavers only — applicants must NOT have commenced any tertiary study (university or diploma-level vocational). Minimum ATAR 92 or listed equivalent (e.g. IB 32, GCE A-Levels 13, SAT 1300 + HS diploma GPA, Gaokao 585/750). Minimum English proficiency requirements. UCAT ANZ or ISAT required — "which will be ranked to determine interview". Successful interview required. MD place is then guaranteed on completion of the Biomedical Science degree "if a minimum GPA of 2.5 is maintained each semester throughout the degree". No high-school subject prerequisites. Full-fee paying only.

None published. (International Welcome Scholarship offers up to 25% fee reduction on most undergraduate degrees — a scholarship, not an admissions adjustment.)

Interview required; format for the international assured pathway not specified beyond "successful interview" (international MD graduate-entry candidates sit a live online panel interview).

The equivalent domestic Assured Pathway is no longer listed for domestic school leavers — the domestic undergraduate route is now the Priority Entry Pathway (first intake 2026–2027). The assured pathway page is presented for international applicants only, currently framed around Semester 1 2026 commencement.

not published — university states places reserved for the Priority Entry Pathway 'will be distributed nationally between campuses and fee types in a similar pattern to the distribution of general places'; no number is published

IMPORTANT: this is a RESERVED-ENTRY (priority) pathway, not a guaranteed place — eligible Biomedical Science graduates compete within their own cohort for a defined number of reserved MD places. Available to students first admitted to the Notre Dame BBiomedSci (incl. double degrees with Laws or Commerce) from 2024 onwards, entering with a valid ATAR selection rank; considered once, in the year of degree completion or the year after (ineligible if further study at another institution in the gap year); max 1.0 FTE credit from another degree. At MD application, must meet all standard GEMSAS requirements PLUS: GEMSAS-calculated GPA >= 6.0, unweighted GAMSAT >= 55, and Casper score no lower than 1 SD below the mean. No published ATAR cut-off for pathway eligibility beyond entry to the BBiomedSci itself.

none published specific to this pathway (standard MD bonuses apply at the GEMSAS stage)

Standard Notre Dame GEMSAS interview: MMI via recorded (asynchronous) online platform

This pathway is itself new: first Priority Entry commences with the 2026–2027 intake, replacing the former domestic 'Assured Pathway' branding (the old assured-pathway program URL now presents the plain BBiomedSci with the Priority Pathway; the guaranteed assured pathway wording is now retained only for international applicants)

not published

International school leavers only, who have NOT commenced any tertiary study (university or diploma-level VET). Minimum ATAR 92 or published equivalent (e.g. IB 32, GCE A-Levels 13, SAT 1300 + HS Diploma GPA, Gaokao 585/750 — university publishes a full equivalency table, flagged as indicative); minimum English proficiency; UCAT ANZ or ISAT required — ranked to determine interview; successful interview. The MD place is GUARANTEED on completion of the BBiomedSci provided a minimum GPA of 2.5 is maintained each semester. No high-school subject prerequisites. Full-fee only for international students.

none published (International Welcome Scholarship of up to 25% fee reduction exists for most undergraduate degrees, incl. BBiomedSci, but is a scholarship, not an admissions adjustment)

Interview required; format for the undergraduate assured-pathway interview not published (Notre Dame's international MD interviews are live online panel interviews)

Published on UAC 2027 course page: "Approximately 30 domestic and 10 international places may be offered." Domestic places are CSP. Gadigal Program: up to 5 places. No BMP/full-fee split published for this pathway.

Current Year 12 (HSC or equivalent) only. Domestic: indicative selection rank 99.95 for 2027 entry; international: indicative ATAR 99.95. Must attend the assessment process (online, 18 Dec 2026 and 18 Jan 2027; eligible candidates must attend the first assessment day after ATAR release; dates not negotiable). No UCAT and no GAMSAT required — students who meet progression requirements (including a zero-credit-point Medicine unit of study) during the undergraduate degree enter the MD without sitting GAMSAT/UCAT or further selection. Gadigal Program (Aboriginal and/or Torres Strait Islander applicants): indicative minimum ATAR 90.00. Regional and Remote Entry Scheme or MySydney applicants: minimum ATAR 99.5 to be considered. Assumed knowledge for BSc Medical Science stream: Mathematics Advanced, Chemistry, Biology. Unconditional offer holders must enrol within 10 calendar days or the offer lapses.

Domestic entry is by "selection rank" (i.e. UAC adjustment factors can apply, but no medicine-specific bonus schedule is published; the effective floor remains 99.95 indicative). Published alternative-ATAR pathways: Gadigal Program for Aboriginal and/or Torres Strait Islander applicants (up to 5 places, indicative ATAR 90.00); Regional and Remote Entry Scheme and MySydney (minimum ATAR 99.5 to be considered). Dalyell Scholars stream (ATAR 98+, by invitation) is an enrichment stream, not an entry concession.

Interview plus written assessment, held online (18 December 2026 and 18 January 2027 for 2027 entry); format beyond "interview and a written assessment" not further specified. Gadigal Program: written assessment plus panel discussion session.

Total intake not published on UNSW admissions pages. Published figures: 28.5% of Commonwealth Supported Places are allocated as Bonded Medical Program (BMP) places; ~350 General Entry interview places; Gateway Entry Scheme ~60 interviews and ~20 offers; Lateral Entry ~30 interviews and up to 10 offers; ~300 international interview places annually. Domestic CSP / BMP / international headcounts: not published.

General entry (Year 12): ATAR 96.00+ without EAS adjustments, plus UCAT ANZ at or above the 50th percentile, plus interview. University applicants/graduates: ATAR-equivalent 96.00+ and GPA 5.5+/7.0 (graduates GPA 5.5+). Rural Entry Admission Pathway: MMM2-7 residence for 5+ consecutive or 10+ cumulative years between ages 5-18 (Health Workforce Locator verified); ATAR 91.00+ (or GPA 4.8+/7.0 for uni students/graduates) and UCAT ANZ 40th percentile+; all eligible rural applicants are interviewed at a rural campus. Gateway Entry Scheme (Year 12 only, designated Gateway school or low-SES area): ATAR 91.00+ and UCAT 50th percentile+. Indigenous Entry Scheme via Nura Gili: no UCAT required; assessed via a 3-week residential Pre-Medicine & Health Program, academic record and interview. International: UCAT ANZ (50th pct+) OR ISAT (minimum 165) — whichever test is submitted first is the one considered; ATAR-equivalent 96.00+. No subject prerequisites: English is assumed knowledge and chemistry study is recommended. Domestic = Australian/NZ citizen or Australian permanent resident. NO external graduate pathway: 'We don't offer a graduate pathway into our program. It's not possible to join our program for the MD component alone.'

No points-style bonuses; adjustments operate as alternative-threshold schemes: Rural Entry Admission Pathway (ATAR 91.00 vs 96.00; UCAT 40th vs 50th percentile; guaranteed interview if eligible); Gateway Entry Scheme (ATAR 91.00, ~20 offers); Indigenous Entry Scheme via Nura Gili (no UCAT, Pre-Medicine Program route). EAS (Educational Access Scheme) and SCATS considered only AFTER meeting minimum selection criteria without adjustments — EAS adjustments cannot be used to reach the ATAR minimums. 2026 lowest selection ranks for reference: 99.75 local general, 94.25 Gateway, 91.05 rural.

Structured interview (UNSW's current published wording: 'Interviews are structured and cover a wide range of relevant topics') with two interviewers drawn from academic staff, medical practitioners and community representatives. Not an MMI. Domestic: face-to-face only (Kensington, or the closest rural clinical campus for rural pathway applicants — Wagga Wagga, Port Macquarie, Coffs Harbour, Albury); rescheduling not permitted and non-attendance terminates the application. International: via Zoom, held monthly June 2026 - January 2027. Domestic interview rounds 17-22 December 2026 and 12-13 January 2027.

1) Medicine Program Redesign launching 2028 and affecting students commencing 2027: refreshed curriculum, enhanced general practice placements, integrated clinical practice/research in Year 4 — duration stays six years. 2) UNSW's Medicine Application Portal (MAP) is being discontinued for the 2027 intake cycle (queries directed to mh.admissions@unsw.edu.au). 3) UNSW moves to a Flex-Semester academic calendar from 2028.

Approximately 30 interview places; 'Up to 10 offers will be made to Lateral Entry applicants.' No further split published.

Domestic applicants only (Australian citizen, Australian permanent resident or NZ citizen) currently in Year 2 of the UNSW Bachelor of Medical Science (BMedSci), with all courses completed at UNSW: 13 core courses completed by end of Term 2 Year 2 to qualify for interview, 16 core courses by end of Year 2 to qualify for an offer. UCAT ANZ minimum 50th percentile. This is UNSW's ONLY graduate-direction stream — it is not open to external graduates and there is no standalone MD entry.

None published for this scheme (rural applicants within BMedSci use the Rural Entry Admission Pathway thresholds instead).

Structured interview with two interviewers (same format as general entry); Lateral Entry interviews held 16 December 2026 at the Kensington campus for 2027 entry.

None specific to this scheme found beyond the university-wide items (Medicine Program Redesign from 2028 affecting 2027 commencers; MAP portal discontinued).

Not published as a separate provisional allocation. UQ publishes only whole-of-MD figures: approximately 275 domestic and approximately 100 international places per year. QTAC lists separate non-bonded (721302) and bonded (721402) codes but no per-code counts.

Must be completing Queensland Year 12 or equivalent in the application year, first attempt; adjusted ATAR 95.00 or equivalent minimum; Queensland Year 12 (or equivalent) English; competitive UCAT ANZ aggregate from the application year (2026-intake interview cutoffs: 2290 general, 1960 Rural Background Sub-Quota — varies yearly); MMI attendance. At least 50% of domestic MMI invitees must be Queensland Year 12 students. To convert the provisional place, students must complete their first bachelor's degree at UQ in minimum time with GPA of at least 5.0/7.0. Regional pathways are domestic-only.

Rural Background Sub-Quota: "Each year, we allocate 28% of all new domestic places in the Doctor of Medicine to applicants from an Australian rural background" (GEMSAS guide states 28.5%); rural applicants faced a lower UCAT interview cutoff (1960 vs 2290 for the 2026 intake). Standard QTAC adjustment factors apply to ATAR (2026 intake lowest selection rank 95.00, but 98.10 median-range effect with adjustments; QTAC median ATAR 99.95 with adjustments). Aboriginal and Torres Strait Islander provisional pathway available (separate ATSIS Unit process). No admissions schemes for international students.

Multiple mini-interview (MMI) via video conferencing, held mid-late November 2026 for 2027 commencement; offers mid-December 2026.

From 2027, UQ adds a new 6-year Bachelor of Medical Science/Doctor of Medicine vertical dual program alongside provisional entry (UQ explicitly states provisional entry, graduate entry and the ATSI pathway all continue). From the 2027 MD intake, MD prerequisite subjects are removed (assumed knowledge only), which affects degree-subject planning during the provisional bachelor's.

Not published (program is new for 2027; no place allocation published; sits within UQ's ~275 domestic MD places per year)

School leavers; adjusted ATAR 95 or equivalent; Queensland Year 12 General English (Units 3&4, C); Queensland Year 12 Mathematical Methods (Units 3&4, C) — note Maths Methods is required for this dual but not for standard provisional entry; Year 12 chemistry/biology recommended but not mandatory; competitive UCAT ANZ aggregate sat in the application year; MMI attendance. Domestic via QTAC; international pending CRICOS registration.

None published specifically for this program yet (standard QTAC adjustment factors apply to ATAR; UQ's 28% rural sub-quota statement applies to all new domestic MD places).

Multiple mini-interview (MMI), consistent with UQ's MD interview process (video conferencing).

This program IS the announced change: first intake 2027, allowing graduation as a doctor in 6 years (at least 1 year earlier than UQ's other school-leaver pathway). UQ confirms it runs alongside, not instead of, provisional entry, graduate entry and the ATSI pathway. International availability pending CRICOS registration.

Total intake not published on the course page. Published components: 20 domestic places held for the Tasmanian Rural Training Stream (Cradle Coast campus only, with written commitment to complete all years at Burnie); approximately 30% of domestic students each year must be enrolled in the Bonded Medical Program (Commonwealth requirement); rural quota of 50% of domestic students from MM2-7 locations including 25% from MM3-7; at least 75% of domestic places offered to Tasmanians. CSP available for domestic students (indicative CSP fee $13,240/yr in 2026). International places offered until filled (2027 international fee $86,573/yr); international seat count not published.

Domestic school leavers: minimum ATAR 95 including any rural adjustment (this is the minimum adjusted ATAR for an application to be considered — meeting it does not guarantee an offer); valid UCAT ANZ score required (valid for the current admission cycle only, i.e. 2026 UCAT for 2027 entry); prerequisites of Tasmanian Senior Secondary Chemistry CHM415115 or equivalent within 5 years (a UTAS foundation Chemistry unit can remedy this before admission) and Year 12 English within 5 years (EAL/D not accepted); must NOT have previously commenced tertiary study (no recorded results at AQF 5+); minimum age 17 at 1 February in year of commencement; ISAT and MCAT not accepted for domestic applicants. Applicants who completed a medicine degree overseas or were excluded from a medical degree elsewhere are not eligible. International school leavers: minimum ATAR 90 or equivalent, plus ISAT (total ≥170, min 165 in both sections) OR MCAT (≥491 within 5 years) OR UCAT ANZ (total in ≥50th percentile); Chemistry prerequisite; English language requirements (e.g. IELTS Academic 7.0).

Rural Application Process (RAP): ATAR adjustment for rural school-leaver applicants (lived in MM2-7 area 5 consecutive or 10 cumulative years) — maximum RAP adjustment is 5 ATAR points, counted within the minimum ATAR 95. Tasmanian Rural Training Stream: 20 places prioritised by 4 published geographic tiers (Tier 1 Tasmanian MM3-7 + postcodes 73xx/72xx; Tier 2 other Tasmanian MM2; Tier 3 interstate MM3-7; Tier 4 interstate MM1-2), with additional scholarships and accommodation. Aboriginal Entry Pathway for Aboriginal and Torres Strait Islander applicants. Special consideration available for circumstances beyond the applicant's control (economic hardship, serious medical condition, disability) — subject prerequisites cannot be waived. No other bonus schemes published.

None. Published wording: "The University of Tasmania does not conduct interviews during selection for the Medicine Program."

All 2027 applications move to a new course code H7X (AQF Level 9), replacing H3X (AQF Level 7) — same 5-year BMedScMD structure. From 2026 the program is offered at the Cradle Coast (Burnie) campus in addition to Hobart and Launceston, with the 20-place Tasmanian Rural Training Stream at Cradle Coast. From 2027, a new quota for University of Tasmania Bachelor of Biomedicine (BBiomed) graduates replaces the old BMedRes pathway on the graduate-entry side (see graduate entry program).

Up to 50% of all MD places are allocated to school leavers (of 206 domestic + 40 international total MD places); 20 of the school-leaver positions are reserved for the Broadway pathway (specified WA schools). Exact CSP/BMP/full-fee split for the school-leaver allocation: not published (BMP is 28.5% of all Commonwealth-supported MD places overall).

Domestic school leavers (Year 12 or equivalent): minimum ATAR 98 for High Academic Achiever, Rural and Broadway categories (Broadway/Rural minimums apply after applicable Broadway adjustments); minimum ATAR 90 for the Indigenous school-leaver pathway; UCAT ANZ sat in the application year; interview. Subject prerequisites for the pathway bachelor: Chemistry ATAR (or bridging unit) and Mathematics Applications ATAR or higher (or bridging unit). International school leavers: ATAR-equivalent 98 plus ISAT at or above the 25th percentile in both sections, plus interview. The MD place is CONDITIONAL: complete UWA's Bachelor of Biomedicine (Specialised) with the Integrated Medical Sciences and Clinical Practice major achieving a minimum selection GPA of 5.5 within the first two years. UWA states minimum ATAR does not guarantee entry. School leavers may defer 1 year (2 years for national service obligations).

Broadway pathway: applicants from specified (typically low-SES) WA schools compete for 20 reserved places with Broadway ATAR adjustments applied toward the ATAR-98 minimum (adjustment size not published on the pages reviewed). Rural quota: rurality rating worth 25% of final ranking. Indigenous school-leaver pathway: reduced ATAR minimum of 90 via School of Indigenous Studies. No other bonus/adjustment schemes published.

Multiple Mini Interview (MMI) for domestic applicants — same 8-station x 7-minute format as graduate entry; school-leaver interviews are held late in the application year (Nov–Dec) with shortlisted candidates advised of dates. International school leavers: panel interview (~50 minutes, 2 interviewers).

Not published for future intakes (2024 cohort was 111 commencing students, per UOW course page). No published cap on the pathway itself; guaranteed interviews limited to top-15 ranked students per entry pathway (see selection).

School-leaver entry to the bachelor: minimum selection rank (ATAR-based) 90; assumed knowledge two units each of English, Mathematics and Science (Mathematics Standard 2, Biology and Chemistry recommended; bridging courses encouraged if no HSC Chemistry/Biology). Progression to the MD still requires meeting all standard MD hurdles (weighted GPA >= 5.5, GAMSAT 50/50 minimums, Casper, UOW first preference). IMPORTANT: this is a guaranteed-INTERVIEW arrangement only — it is NOT a guaranteed or conditional MD place.

None specific to this pathway published beyond the guaranteed-interview arrangement; as UOW graduates, completing students would later qualify for the MD "UOW Graduate" bonus (and "UOW Graduate + Academic Excellence" if GPA >= 6.5).

Same as the MD: 8-station live online MMI.

"approximately 120 places" total (WSU MD enrolment places page); "The School reserves approximately 20 places for International students each year" (international page states a "minimum of 20 places"); "minimum of 15 places" reserved for Rural Entry Admission Scheme (REAS) students; CSP vs BMP split not published (both place types exist)

Domestic: Australian/NZ citizen, permanent resident or permanent humanitarian visa. Academic thresholds: ATAR 95.5 (or equivalent) general; 93.5 for Greater Western Sydney (GWS) applicants (lived at a School of Medicine designated GWS postcode for at least 5 consecutive years prior to program commencement); 91.5 for Rural Entry Admission Scheme (ASGS-RA 2-5 residence for 10 years cumulative or 5 consecutive since age 5, verified via DoctorConnect). Graduates/non-school-leavers enter the same course via minimum GPA tables (e.g. completed undergraduate degree GPA 5.5 non-GWS / 5.2 GWS / 4.9 rural; honours and research masters no minimum). UCAT ANZ must be sat in the year of application (previous years' results not accepted); UCAT threshold not disclosed, set annually by cohort performance, and GWS applicants may face a lower UCAT threshold. No HSC subject prerequisites published. International: ATAR-equivalent 93.5 (IB 37, GCE AAA*) or GPA tables; ISAT (International Student Admission Test) used to rank when places are limited; interview required; no credit for partial overseas medical degrees.

No points-based ATAR adjustment scheme published. Instead, concessional entry thresholds: Greater Western Sydney residents ATAR 93.5 (vs 95.5) plus potentially lower UCAT interview threshold; Rural Entry Admission Scheme ATAR 91.5 with a minimum of 15 dedicated places; Aboriginal and Torres Strait Islander Pathway — separate admission process (no published ATAR minimum or UCAT mention): NSW HSC or tertiary equivalent, confirmation-of-identity documentation, and a panel interview (Dean, Professor of Aboriginal and Torres Strait Islander Health, an academic, and a community member) held early November. No elite-athlete or other adjustment schemes published for the MD.

Multi-station Mini Interview (MMI), held late November, conducted via Zoom/video conference; a series of stations each with a separate interviewer, approximately 8 minutes per station

The WSU/CSU Joint Program in Medicine has ended: from 2027 entry WSU and Charles Sturt run separate, independently accredited medicine programs with separate UAC codes (WSU 725505; CSU 214478) — confirmed by UAC's medicine key-dates listing (which lists the two courses separately) and unverified — do not publish as fact (the direct quote could not be confirmed: study.csu.edu.au and CSU School of Medicine pages return HTTP 403 to automated fetching; the CSU 2026 handbook confirms the course exists but contains no such wording). The underlying facts ARE confirmed from primary sources — UAC lists WSU 725505 and CSU 214478 as separate courses, and WSU states transfers between the two programs are not permitted — so keep the separation claim but drop or re-source the attributed CSU quote. WSU also states transfers between the WSU and CSU BClinSci(Med)/MD programs are not permitted. No changes to WSU's own selection weighting announced.

47 Commonwealth Supported Places per year (CSU news, 25 Nov 2025: an additional 10 CSPs "from next year" takes "the course" to 47 CSPs). Rural vs non-rural split of places not published on primary sources; BMP places exist and are "automatically allocate[d]... based on final ranking" (number not published); no international offering (CSU: "This course has no international offering"); no full-fee domestic places published.

Australian citizens and permanent residents only (no international intake). Academic thresholds: non-rural ATAR 95.5 (or IB 38+, GCE AAA*, or GPA tables — e.g. completed undergraduate degree GPA 5.5; honours/research masters no minimum); Rural Entry Admissions Scheme ATAR 91.5 (or IB 35+, or GPA tables — e.g. completed undergraduate degree GPA 4.9), with rural origin defined as "residency for at least 10 years cumulatively or any 5 years consecutively in an ASGS-RA 2-5 area since the age of five years" (verified via DoctorConnect + Rural Confirmation form in the UAC application). UCAT ANZ must be sat in the year of application (results valid only for that year); UCAT ranks applicants for interview and the required level "will not be disclosed". Geographic interview allocation: 80% of interview places to NSW applicants, 20% to interstate. Minimum 32 credit points required for tertiary qualifications to be GPA-assessed. No HSC subject prerequisites published.

No points-based ATAR adjustment scheme published. Concessional/quota arrangements instead: Rural Entry Admissions Scheme threshold ATAR 91.5 vs 95.5 non-rural; First Nations applicants have a separate admission process (NSW HSC or tertiary equivalent, confirmation-of-identity documentation, and a panel interview held late November–early December, offers based holistically on motivation, academic records and community involvement); a minimum of six interview positions guaranteed for current Charles Sturt students who meet a GPA target after 1–2 years of any CSU course and sit UCAT ANZ (must meet all Rural Entry Admissions Scheme conditions); Central West Medical Association scholarship for First Nations and financially disadvantaged rural/remote first-year students.

Multi-Station Mini Interview (MMI), held virtually via Zoom in November, run from Orange; a series of stations each with a separate interviewer, 8 minutes per station. First Nations pathway uses a panel interview instead.

Two official changes: (1) the WSU/CSU Joint Program in Medicine has been discontinued — from 2027 entry CSU delivers its own "newly accredited, independent program" from Orange with its own UAC code 214478 and its own School of Rural Medicine, first cohort commencing 1 March 2027 (transfers between the CSU and WSU programs are not permitted); (2) the Australian Government allocated CSU an additional 10 CSPs per year, taking the course to 47 CSPs (announced 25 November 2025), within the national expansion of 50 additional CSP medicine places per year for three years (150/year from 2028); CSU has said it will seek further allocations.